NCT04986410 is a clinical trial of CCTA, CT-MPI, CT-FFR, SPECT-MPI in Coronary Artery Disease, sponsored by Qilu Hospital of Shandong University.

Who is sponsoring NCT04986410?

NCT04986410 is sponsored by Qilu Hospital of Shandong University.

What drugs are being tested in NCT04986410?

Interventions in NCT04986410: CCTA, CT-MPI, CT-FFR, SPECT-MPI.

What condition does NCT04986410 study?

NCT04986410 studies Coronary Artery Disease.

Is NCT04986410 still recruiting?

NCT04986410 is currently completed. Last updated 2 August 2021.

Last reviewed 2021-08-02 · How we verify

NCT04986410

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quantitative Analysis of Functional CT Imaging of Coronary Atherosclerosis

Completed Last updated 2 August 2021

What this trial tests

trial testing CCTA, CT-MPI, CT-FFR, SPECT-MPI in Coronary Artery Disease in 640 participants. Completed in 31 December 2020.

Timeline

1 July 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Qilu Hospital of Shandong University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	640
Start date	1 July 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across China

Drugs / interventions tested

CCTA, CT-MPI, CT-FFR, SPECT-MPI

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Qilu Hospital of Shandong University

Who can join

Adults 18 to 85, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this prospective observational study is to evaluate the diagnostic and prognostic performance of a "one-stop" comprehensive coronary artery anatomy and function assessment for CAD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Identification of Flow-Limiting Coronary Stenosis With PCS: A New Cost-Effective Index Derived From the Product of Corrected TIMI Frame Count and Percent Diameter Stenosis.
Li X, Lyu L, Yang W, Pan J, et al · · 2021 · cited 3× · PMID 34805299 · DOI 10.3389/fcvm.2021.718935

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Qilu Hospital of Shandong University trials

Trials by the same sponsor.

NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
NCT07140419 — Coronary Computed Tomographic Angiography Combined With CT-FFR in Intermediate-Risk Chest Pain Patients. · NA · not yet recruiting
NCT07509879 — Research on the Molecular Mechanism of Cognitive Differences Between Williams Syndrome and Autism Spectrum Disorder · not yet recruiting
NCT07537374 — A Case-Control Observational Study of Peripheral Blood-Derived iPSC Models to Investigate Oligodendrocyte Lineage Develo · not yet recruiting
NCT07505940 — Bilateral Comparison of Unilateral Sacral Neuromodulation Test Stimulation in the Treatment of Neurogenic Bladder · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04986410 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qilu Hospital of Shandong University
Last refreshed: 2 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04986410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing